Back to Atlas
APotentially durableStandard research/education caution
CMP-0051
Research/Experimental
Follistatin-315
Ergogenic / Myostatin
Potential skeletal muscle hypertrophy and preservation
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Glycoprotein / myostatin inhibitor
- Primary mechanism
- Binds myostatin/activin-family ligands
- Primary market use
- Muscle wasting / performance
Pharmacology
- Molecular weight (Da)
- ~35,000
- Oral bioavailability
- N/A
- Half-life
- 6 to 8 hours subQ
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/Human-adjacent
- Clinical status
- Research/Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Durable structural effect depends on retained muscle accretion